SUMMIT NDA for bezuclastinib in patients with NonAdvSM submitted in December 2025; APEX NDA submission for bezuclastinib in patients with AdvSM on track for 1H 2026PEAK NDA initiated for bezuclastinib ...
Tb/s/λ-Class Co-Frequency Co-Time Full-Duplex WDM Transmission over 100-km AR-HCF in the S+C+L-band
Abstract: Optical networks aim to achieve a higher rate per channel and larger capacity per fiber while lowering the cost per bit. Ultra-wide band (UWB) wavelength-division multiplexing (WDM) over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results